Status:
RECRUITING
Fulminant Severe CAP - an Observational Study
Lead Sponsor:
University of Trieste
Conditions:
Community-acquired Pneumonia
Severe Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
Severe community-acquired pneumonia (CAP) represents a major cause of hospital mortality. Among severe CAP cases, some exhibit a rapidly progressive evolution, leading to severe ARDS/acute respiratory...
Detailed Description
A list of consecutive patients with severe CAP from the 5 participating centers from January 2018 to July 2024. Patients recruited for concomitant randomized clinical trials were allowed. Each Center ...
Eligibility Criteria
Inclusion
- severe community acquired pneumonia according to ATS/IDSA -
Exclusion
- incomplete outcome data
- \-
Key Trial Info
Start Date :
January 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
1460 Patients enrolled
Trial Details
Trial ID
NCT06516601
Start Date
January 2 2018
End Date
October 1 2024
Last Update
July 24 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Marco Confalonieri
Trieste, TS, Italy, 34149
2
SC Pneumologia, Azienda Sanitaria Universitaria Giuliano-Isontina
Trieste, Italy, 34126